| scholarly article | Q13442814 |
| P50 | author | Julian R Marchesi | Q61126705 |
| F. Susan Wong | Q63411298 | ||
| Li Wen | Q88313570 | ||
| P2093 | author name string | Andrew Benson | |
| Jian Peng | |||
| Sukanya Narasimhan | |||
| P2860 | cites work | Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study | Q39585691 |
| Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse | Q40409987 | ||
| Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention | Q41775548 | ||
| Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β. | Q42702492 | ||
| A missing link in the hygiene hypothesis? | Q53873028 | ||
| Hygiene and Other Early Childhood Influences on the Subsequent Function of the Immune System | Q58826757 | ||
| Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells | Q58826830 | ||
| Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses | Q60556933 | ||
| Intestinal lactobacilli and the DC-SIGN gene for their recognition by dendritic cells play a role in the aetiology of allergic manifestations | Q61988338 | ||
| The discovery and development of the BB rat colony: an animal model of spontaneous diabetes mellitus | Q71773270 | ||
| Thyroid-specific expression of IFN-gamma limits experimental autoimmune thyroiditis by suppressing lymphocyte activation in cervical lymph nodes | Q73419625 | ||
| Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat | Q77307112 | ||
| The intestinal microflora in allergic Estonian and Swedish 2-year-old children | Q77321890 | ||
| Molecular monitoring of succession of bacterial communities in human neonates | Q24534898 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| Toward defining the autoimmune microbiome for type 1 diabetes | Q24629032 | ||
| Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 | ||
| Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
| Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies | Q26862839 | ||
| Bacterial epidemiology and biology - lessons from genome sequencing | Q27499569 | ||
| A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak | Q28709555 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function | Q29617462 | ||
| The effect of infections on susceptibility to autoimmune and allergic diseases | Q29618525 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| The rise of childhood type 1 diabetes in the 20th century. | Q30332258 | ||
| Landscape of next-generation sequencing technologies. | Q34187217 | ||
| The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine | Q34224134 | ||
| Hygiene hypothesis and autoimmune diseases | Q34233260 | ||
| The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders | Q34647496 | ||
| Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology | Q34822378 | ||
| Rapid single-colony whole-genome sequencing of bacterial pathogens | Q35076491 | ||
| Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. | Q36131743 | ||
| Role of bacillus Calmette-Guérin as an immunomodulator for the prevention and treatment of allergy and asthma | Q36303732 | ||
| Qa-2-dependent selection of CD8alpha/alpha T cell receptor alpha/beta(+) cells in murine intestinal intraepithelial lymphocytes | Q36368555 | ||
| Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease | Q36393941 | ||
| Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak | Q36559099 | ||
| Gender bias in autoimmunity is influenced by microbiota. | Q37294725 | ||
| Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis | Q37331576 | ||
| Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis | Q37361475 | ||
| Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells | Q37590759 | ||
| Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation | Q37707264 | ||
| Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics | Q38952811 | ||
| P304 | page(s) | 85-94 | |
| P577 | publication date | 2014-04-22 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | Long term effect of gut microbiota transfer on diabetes development | |
| P478 | volume | 53 |
| Q88956194 | A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies |
| Q26795697 | A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models |
| Q28817498 | A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development |
| Q35660484 | A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia |
| Q35694206 | A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. |
| Q91842426 | Altered Gut Microbiota Activate and Expand Insulin B15-23-Reactive CD8+ T Cells |
| Q40989594 | Antibiotic-treated versus germ-free rodents for microbiota transplantation studies |
| Q36277657 | Antibiotics, gut microbiota, environment in early life and type 1 diabetes. |
| Q39017669 | Beyond Genetics: What Causes Type 1 Diabetes |
| Q28391541 | Can exposure to environmental chemicals increase the risk of diabetes type 1 development? |
| Q38267786 | Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes |
| Q35595168 | Cross-fostering immediately after birth induces a permanent microbiota shift that is shaped by the nursing mother |
| Q35809057 | DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives |
| Q36017830 | Different immunological responses to early-life antibiotic exposure affecting autoimmune diabetes development in NOD mice |
| Q35443254 | Does the microbiota play a role in the pathogenesis of autoimmune diseases? |
| Q36218874 | Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus |
| Q91711356 | Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms |
| Q35391267 | Evaluation of serum & salivary IgA in patients with type 1 diabetes |
| Q35742093 | Genetic and environmental control of host-gut microbiota interactions |
| Q98726635 | Gut microbiota and diabetes: From correlation to causality and mechanism |
| Q100946013 | Gut microbiota in pancreatic diseases: possible new therapeutic strategies |
| Q38554722 | Human autoimmune diseases: a comprehensive update |
| Q38767617 | Intraportal islet transplantation: the impact of the liver microenvironment |
| Q40631825 | Is there a role for gut microbiota in type 1 diabetes pathogenesis? |
| Q92510586 | Linggui Zhugan Formula Improves Glucose and Lipid Levels and Alters Gut Microbiota in High-Fat Diet-Induced Diabetic Mice |
| Q89999319 | MAIT cells in metabolic diseases |
| Q37272130 | Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice |
| Q35623830 | Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale |
| Q85939692 | Multicenter Evaluation of Current Knowledge of Intestinal Transplantation and Rehabilitation Among Trainee Physicians |
| Q90334692 | New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes |
| Q91670627 | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
| Q36031725 | Piglet nasal microbiota at weaning may influence the development of Glässer's disease during the rearing period |
| Q26766139 | Recent advances in understanding Type 1 Diabetes |
| Q40096435 | Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment. |
| Q42706747 | Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus |
| Q89365112 | TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells |
| Q90311901 | Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products |
| Q39873963 | The Gut Microbiome in the NOD Mouse. |
| Q89819674 | The Interplay between Immune System and Microbiota in Diabetes |
| Q52315444 | The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. |
| Q51149244 | The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. |
| Q88575378 | The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus |
| Q35655645 | The gut microbiota and Type 1 Diabetes. |
| Q47611584 | The hygiene hypothesis in autoimmunity: the role of pathogens and commensals |
| Q35787117 | The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes |
| Q52715835 | The microbiome and autoimmunity: a paradigm from the gut-liver axis. |
| Q35142299 | The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity |
| Q35884681 | The role of the intestinal microbiota in type 1 diabetes mellitus |
| Q41430377 | Type 1 Diabetes: Urinary Proteomics and Protein Network Analysis Support Perturbation of Lysosomal Function |
| Q28087084 | Type 1 diabetes and gut microbiota: Friend or foe? |
| Q35331225 | Understanding the role of gut microbiome in metabolic disease risk. |
| Q26801962 | iNKT and MAIT Cell Alterations in Diabetes |
Search more.